Report cover image

Biocartis Group NV (BCART) - Product Pipeline Analysis, 2022 Update

Publisher GlobalData
Published Feb 07, 2023
Length 68 Pages
SKU # GBDT17776251

Description

Summary

Biocartis Group NV (Biocartis) operates as a molecular diagnostics company. It provides personalized medicine for patients through its molecular diagnostics. The company undertakes the development of diagnostics technology platforms for multiplexed detection of bio-analytes, with oncology as its key focus area. Its Idylla is a molecular diagnostics system that provides easy access to clinical molecular diagnostic information. Biocartis also offers a wide range of oncology assays such as Idylla BRAF Mutation Test, Idylla EGFR Mutation Test, Idylla KRAS Mutation Test, and Idylla NRAS Mutation. The company has operations in Belgium and Switzerland. Biocartis is headquartered in Mechelen, Belgium.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Biocartis Group NV
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

68 Pages
Biocartis Group NV Company Overview
Biocartis Group NV Company Snapshot
Biocartis Group NV Pipeline Products and Ongoing Clinical Trials Overview
Biocartis Group NV – Pipeline Analysis Overview
Biocartis Group NV - Key Facts
Biocartis Group NV - Major Products and Services
Biocartis Group NV Pipeline Products by Development Stage
Biocartis Group NV Pipeline Products Overview
Diagnostic Brain Assay
Diagnostic Brain Assay Product Overview
EGFR Colon Cancer Test
EGFR Colon Cancer Test Product Overview
Idylla - EGFR/BRAF+ Test
Idylla - EGFR/BRAF+ Test Product Overview
Idylla - KRAS-NRAS-BRAF Test
Idylla - KRAS-NRAS-BRAF Test Product Overview
Idylla ABC Assay
Idylla ABC Assay Product Overview
Idylla Blood Stream Infections Panel
Idylla Blood Stream Infections Panel Product Overview
Idylla Companion Diagnostic Assay
Idylla Companion Diagnostic Assay Product Overview
Idylla ctEGFR Assay
Idylla ctEGFR Assay Product Overview
Idylla EGFR CDx Assay
Idylla EGFR CDx Assay Product Overview
Idylla Endometrium Assay
Idylla Endometrium Assay Product Overview
Idylla Endpoint CDx Test
Idylla Endpoint CDx Test Product Overview
Idylla Extended KRAS Mutation Test
Idylla Extended KRAS Mutation Test Product Overview
Idylla Extended NRAS Mutation Test
Idylla Extended NRAS Mutation Test Product Overview
Idylla Hematology Assay
Idylla Hematology Assay Product Overview
Idylla HPV Test - Head And Neck Cancer
Idylla HPV Test - Head And Neck Cancer Product Overview
Idylla Immuno Tx Panel Test
Idylla Immuno Tx Panel Test Product Overview
Idylla KRAS Mutation Test
Idylla KRAS Mutation Test Product Overview
Idylla Meningitis Assay
Idylla Meningitis Assay Product Overview
Idylla MERS Assay
Idylla MERS Assay Product Overview
Idylla MSI CDx
Idylla MSI CDx Product Overview
Idylla MSI Test
Idylla MSI Test Product Overview
Idylla Neuro Panel Test
Idylla Neuro Panel Test Product Overview
Idylla Neurological Disease Assay
Idylla Neurological Disease Assay Product Overview
Idylla NGS Prep Panel - Lung
Idylla NGS Prep Panel - Lung Product Overview
Idylla NRAS-BRAF Mutation Test
Idylla NRAS-BRAF Mutation Test Product Overview
Idylla Oncotype DX Prostate
Idylla Oncotype DX Prostate Product Overview
Idylla Resistance Monitoring Assay
Idylla Resistance Monitoring Assay Product Overview
Idylla Retrieve - NGS Hotspot Panel Assay
Idylla Retrieve - NGS Hotspot Panel Assay Product Overview
Idylla Sepsis Assay
Idylla Sepsis Assay Product Overview
Idylla Syndromic Immunocompromised Panel
Idylla Syndromic Immunocompromised Panel Product Overview
Idylla Syndromic Panel - Tropical Fever
Idylla Syndromic Panel - Tropical Fever Product Overview
Idylla System - Multiplex Companion Diagnostics Test
Idylla System - Multiplex Companion Diagnostics Test Product Overview
Idylla Test - Cell Therapy Monitoring
Idylla Test - Cell Therapy Monitoring Product Overview
Idylla Viral Load Assay - HBV
Idylla Viral Load Assay - HBV Product Overview
Idylla Viral Load Assay - HCV
Idylla Viral Load Assay - HCV Product Overview
Idylla Viral Load Assay - HIV
Idylla Viral Load Assay - HIV Product Overview
Idylla-ctBRAF Test - Melanoma
Idylla-ctBRAF Test - Melanoma Product Overview
SeptiCyte Triage
SeptiCyte Triage Product Overview
Biocartis Group NV - Key Competitors
Biocartis Group NV - Key Employees
Biocartis Group NV - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Biocartis Group NV, Recent Developments
Jan 17, 2023: Biocartis Group NV: Biocartis meets 2022 key objectives
Oct 21, 2022: Biocartis Reports Results of Third Quarter of 2022
Aug 25, 2022: Biocartis Announces 2022 Half-Year Results on 1 September 2022
Apr 21, 2022: Biocartis Reports Results of First Quarter of 2022: On Track to Deliver on Full-Year Guidance, Gross Margin on Products of 35%
Feb 17, 2022: Biocartis Group announces 2021 full year results on 24 february 2022
Jan 10, 2022: Biocartis meets 2021 key objectives
Nov 10, 2021: Biocartis Q3 2021 Business Update and the Outlook
Sep 23, 2021: Biocartis announces restart of its high-throughput cartridge manufacturing line
Aug 17, 2021: Second update on fire incident at Biocartis warehouse
Aug 02, 2021: Update on fire incident at Biocartis warehouse
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Table 1: Biocartis Group NV Pipeline Products and Ongoing Clinical Trials Overview
Table 2: Biocartis Group NV Pipeline Products by Equipment Type
Table 3: Biocartis Group NV Pipeline Products by Indication
Table 4: Biocartis Group NV, Key Facts
Table 5: Biocartis Group NV, Major Products and Services
Table 6: Biocartis Group NV Number of Pipeline Products by Development Stage
Table 7: Biocartis Group NV Pipeline Products Summary by Development Stage
Table 8: Diagnostic Brain Assay - Product Status
Table 9: Diagnostic Brain Assay - Product Description
Table 10: EGFR Colon Cancer Test - Product Status
Table 11: EGFR Colon Cancer Test - Product Description
Table 12: Idylla - EGFR/BRAF+ Test - Product Status
Table 13: Idylla - EGFR/BRAF+ Test - Product Description
Table 14: Idylla - KRAS-NRAS-BRAF Test - Product Status
Table 15: Idylla - KRAS-NRAS-BRAF Test - Product Description
Table 16: Idylla ABC Assay - Product Status
Table 17: Idylla ABC Assay - Product Description
Table 18: Idylla Blood Stream Infections Panel - Product Status
Table 19: Idylla Blood Stream Infections Panel - Product Description
Table 20: Idylla Companion Diagnostic Assay - Product Status
Table 21: Idylla Companion Diagnostic Assay - Product Description
Table 22: Idylla ctEGFR Assay - Product Status
Table 23: Idylla ctEGFR Assay - Product Description
Table 24: Idylla EGFR CDx Assay - Product Status
Table 25: Idylla EGFR CDx Assay - Product Description
Table 26: Idylla Endometrium Assay - Product Status
Table 27: Idylla Endometrium Assay - Product Description
Table 28: Idylla Endpoint CDx Test - Product Status
Table 29: Idylla Endpoint CDx Test - Product Description
Table 30: Idylla Extended KRAS Mutation Test - Product Status
Table 31: Idylla Extended KRAS Mutation Test - Product Description
Table 32: Idylla Extended NRAS Mutation Test - Product Status
Table 33: Idylla Extended NRAS Mutation Test - Product Description
Table 34: Idylla Hematology Assay - Product Status
Table 35: Idylla Hematology Assay - Product Description
Table 36: Idylla HPV Test - Head And Neck Cancer - Product Status
Table 37: Idylla HPV Test - Head And Neck Cancer - Product Description
Table 38: Idylla Immuno Tx Panel Test - Product Status
Table 39: Idylla Immuno Tx Panel Test - Product Description
Table 40: Idylla KRAS Mutation Test - Product Status
Table 41: Idylla KRAS Mutation Test - Product Description
Table 42: Idylla Meningitis Assay - Product Status
Table 43: Idylla Meningitis Assay - Product Description
Table 44: Idylla MERS Assay - Product Status
Table 45: Idylla MERS Assay - Product Description
Table 46: Idylla MSI CDx - Product Status
Table 47: Idylla MSI CDx - Product Description
Table 48: Idylla MSI Test - Product Status
Table 49: Idylla MSI Test - Product Description
Table 50: Idylla Neuro Panel Test - Product Status
Table 51: Idylla Neuro Panel Test - Product Description
Table 52: Idylla Neurological Disease Assay - Product Status
Table 53: Idylla Neurological Disease Assay - Product Description
Table 54: Idylla NGS Prep Panel - Lung - Product Status
Table 55: Idylla NGS Prep Panel - Lung - Product Description
Table 56: Idylla NRAS-BRAF Mutation Test - Product Status
Table 57: Idylla NRAS-BRAF Mutation Test - Product Description
Table 58: Idylla Oncotype DX Prostate - Product Status
Table 59: Idylla Oncotype DX Prostate - Product Description
Table 60: Idylla Resistance Monitoring Assay - Product Status
Table 61: Idylla Resistance Monitoring Assay - Product Description
Table 62: Idylla Retrieve - NGS Hotspot Panel Assay - Product Status
Table 63: Idylla Retrieve - NGS Hotspot Panel Assay - Product Description
Table 64: Idylla Sepsis Assay - Product Status
Table 65: Idylla Sepsis Assay - Product Description
Table 66: Idylla Syndromic Immunocompromised Panel - Product Status
Table 67: Idylla Syndromic Immunocompromised Panel - Product Description
Table 68: Idylla Syndromic Panel - Tropical Fever - Product Status
Table 69: Idylla Syndromic Panel - Tropical Fever - Product Description
Table 70: Idylla System - Multiplex Companion Diagnostics Test - Product Status
Table 71: Idylla System - Multiplex Companion Diagnostics Test - Product Description
Table 72: Idylla Test - Cell Therapy Monitoring - Product Status
Table 73: Idylla Test - Cell Therapy Monitoring - Product Description
Table 74: Idylla Viral Load Assay - HBV - Product Status
Table 75: Idylla Viral Load Assay - HBV - Product Description
Table 76: Idylla Viral Load Assay - HCV - Product Status
Table 77: Idylla Viral Load Assay - HCV - Product Description
Table 78: Idylla Viral Load Assay - HIV - Product Status
Table 79: Idylla Viral Load Assay - HIV - Product Description
Table 80: Idylla-ctBRAF Test - Melanoma - Product Status
Table 81: Idylla-ctBRAF Test - Melanoma - Product Description
Table 82: SeptiCyte Triage - Product Status
Table 83: SeptiCyte Triage - Product Description
Table 84: Biocartis Group NV, Key Employees
Table 85: Biocartis Group NV, Subsidiaries
Table 86: Glossary
List of Figures
Figure 1: Biocartis Group NV Pipeline Products by Equipment Type
Figure 2: Biocartis Group NV Pipeline Products by Development Stage

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us